Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 1:42 pm Sale |
2024-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Ayrton Capital LLC | 774,100 9.900% |
-182,129 (-19.05%) |
Filing History |
| 2025-01-15 4:03 pm Purchase |
2024-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 714,844 9.990% |
714,844 (New Position) |
Filing History |
| 2024-11-13 11:19 am Sale |
2024-09-30 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 793,747 9.990% |
-109,665 (-12.14%) |
Filing History |
| 2024-05-30 4:05 pm Purchase |
2024-05-23 | 13D | MyMD Pharmaceuticals, Inc. MYMD |
PharmaCyte Biotech Inc. PMCB |
11,563,878 83.400% |
11,563,878 (New Position) |
Filing History |
| 2024-02-14 3:38 pm Sale |
2023-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Ayrton Capital LLC | 956,229 9.900% |
-794,483 (-45.38%) |
Filing History |
| 2024-02-06 09:56 am Sale |
2023-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 903,412 9.990% |
-1,015,547 (-52.92%) |
Filing History |
| 2023-11-22 4:00 pm Purchase |
2023-11-14 | 13D | Femasys Inc. FEMY |
PharmaCyte Biotech Inc. PMCB |
12,711,864 37.000% |
12,711,864 (New Position) |
Filing History |
| 2023-06-16 5:22 pm Unchanged |
2023-06-15 | 13D | PharmaCyte Biotech, Inc. PMCB |
Iroquois Capital Management, LLC | 2,280,000 4.990% |
0 (Unchanged) |
Filing History |
| 2023-05-19 5:19 pm Purchase |
2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Ayrton Capital LLC | 1,750,712 9.990% |
1,750,712 (New Position) |
Filing History |
| 2023-05-12 4:22 pm Purchase |
2023-05-10 | 13D | PharmaCyte Biotech, Inc. PMCB |
Iroquois Capital Management, LLC | 2,280,000 7.000% |
890,131 (+64.04%) |
Filing History |
| 2023-02-14 4:30 pm Sale |
2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Shay Capital LLC | 0 0.000% |
-1,037,882 (Position Closed) |
Filing History |
| 2023-02-08 06:05 am Purchase |
2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 1,918,959 9.990% |
687,477 (+55.83%) |
Filing History |
| 2023-01-10 11:57 am Purchase |
2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
SABBY MANAGEMENT LLC | 934,456 11.000% |
673,528 (+258.13%) |
Filing History |
| 2022-10-20 10:38 am Purchase |
2022-10-10 | 13G | PharmaCyte Biotech, Inc. PMCB |
Shay Capital LLC | 1,037,882 5.000% |
1,037,882 (New Position) |
Filing History |
| 2022-08-15 5:38 pm Purchase |
2022-08-15 | 13D | PharmaCyte Biotech, Inc. PMCB |
Iroquois Capital Management, LLC | 1,389,869 6.700% |
12,400 (+0.90%) |
Filing History |
| 2022-07-11 5:11 pm Purchase |
2022-07-07 | 13D | PharmaCyte Biotech, Inc. PMCB |
Iroquois Capital Management, LLC | 1,377,469 6.600% |
118,678 (+9.43%) |
Filing History |
| 2022-06-23 3:40 pm Purchase |
2022-06-21 | 13D | PharmaCyte Biotech, Inc. PMCB |
Iroquois Capital Management, LLC | 1,258,791 6.700% |
210,145 (+20.04%) |
Filing History |
| 2022-02-11 07:49 am Purchase |
2021-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 1,231,482 5.600% |
168,272 (+15.83%) |
Filing History |
| 2022-01-04 10:43 am Sale |
2021-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
SABBY MANAGEMENT LLC | 260,928 11.000% |
-985,317 (-79.06%) |
Filing History |
| 2021-11-04 07:38 am Purchase |
2021-10-27 | 13D | PharmaCyte Biotech, Inc. PMCB |
Iroquois Capital Management, LLC | 1,048,646 5.100% |
1,048,646 (New Position) |
Filing History |